Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amlodipine; valsartan; hydrochlorothiazide - film-coated tablet - 10/160/12.5 milligram(s) - valsartan, amlodipine and hydrochlorothiazide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amlodipine; valsartan; hydrochlorothiazide - film-coated tablet - 10/160/25 milligram(s) - valsartan, amlodipine and hydrochlorothiazide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amlodipine; valsartan; hydrochlorothiazide - film-coated tablet - 10/320/25 milligram(s) - valsartan, amlodipine and hydrochlorothiazide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amlodipine; valsartan; hydrochlorothiazide - film-coated tablet - 5/160/12.5 milligram(s) - valsartan, amlodipine and hydrochlorothiazide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - amlodipine; valsartan; hydrochlorothiazide - film-coated tablet - 5/160/25 milligram(s) - valsartan, amlodipine and hydrochlorothiazide

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amlodipine 5 mg - amlodipine/valsartan/hydrochlorothiazide is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including amlodipine, hydrochlorothiazide, and the arb class to which valsartan principally belongs. there are no controlled trials demonstrating risk reduction with amlodipine/valsartan/hydrochlorothiazide. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education p

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - valsartan 160 mg; amlodipine besilate 13,88 mg - eq. amlodipine 10 mg; hydrochlorothiazide 25 mg - film-coated tablet - 10 mg - 160 mg - 25 mg - valsartan 160 mg; hydrochlorothiazide 25 mg; amlodipine besilate 13.88 mg - valsartan, amlodipine and hydrochlorothiazide

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - valsartan 320 mg; amlodipine besilate 13,88 mg - eq. amlodipine 10 mg; hydrochlorothiazide 25 mg - film-coated tablet - 10 mg - 320 mg - 25 mg - valsartan 320 mg; hydrochlorothiazide 25 mg; amlodipine besilate 13.88 mg - valsartan, amlodipine and hydrochlorothiazide

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - valsartan; hydrochlorothiazide - film-coated tablet - 80 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; valsartan and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - valsartan; hydrochlorothiazide - film-coated tablet - 160 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; valsartan and diuretics